Form 4: Progyny Director Kevin K. Gordon Reports Stock Transactions

Director Kevin K. Gordon reports acquisition and disposal of Progyny, Inc. stock and stock options.

Summary

• Kevin K. Gordon, a director of Progyny, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 23, 2024, Gordon acquired 5,147 shares of common stock underlying restricted stock units (RSUs) at $0, which will vest on May 23, 2025, contingent upon continued service.
• On the same date, Gordon disposed of 8,801 shares of common stock.
• Gordon also acquired 23,212 stock options with an exercise price of $27.15, vesting on May 23, 2025, also contingent upon continued service.
• Following these transactions, Gordon directly owns 23,212 derivative securities and indirectly owns 6,200 shares through a revocable trust.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock transactions. The acquisition of options is mildly positive, while the disposal of shares is mildly negative, balancing each other out.

Positives

• Acquisition of stock options indicates confidence in the company's future performance.

Negatives

• The disposal of 8,801 shares could be interpreted negatively, although the overall context suggests routine transactions.

Risks

• The vesting of RSUs and stock options is contingent upon continued service, creating a potential risk if Gordon were to leave the company before the vesting date.

Future Outlook

The vesting of RSUs and stock options on May 23, 2025, is contingent upon the Reporting Person's continued service.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.

Comparison to Industry Standards

• Comparing the vesting schedules and option grants to similar companies in the healthcare benefits industry, such as Teladoc Health or Accolade, can provide context on the competitiveness of Progyny's compensation packages.
• Reviewing the ownership stakes of other directors and executives in comparable firms can offer insights into the relative alignment of management's interests with those of shareholders.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, depending on how investors interpret the director's actions.

Key Dates